Search
-
Behavioural Science
Behavioural Science at Ipsos is the use of psychology to help both public sector and brands meet their goals. The theories and methods from psychology work alongside MR techniques to understand and predict behaviour, generating total customer understanding.
-
[WEBINAR] Illuminating the Lottery Landscape Through Digital Qual
On November 7, join us for a complimentary webinar where we will illuminate how to push your research beyond focus groups, and leverage the role digital qualitative solutions can play in understanding your customer within the lottery and gaming sector.
-
[WEBINAR] Consumption Trends in Canada
View this on demand webinar for insights gleaned from CHATS, our annual study of Canadian Consumption Habits and Attitudinal Trends.
-
[WEBINAR] The Future of Omnichannel Retail
October 12 - Join Ipsos for a complimentary webinar during which we’ll share our version of the future of research, previewing the shape of things to come in our increasingly databased omnichannel retail world.
-
[EVENT] Grocerant Summit
On September 27, join Ipsos’ Alison Chaltas and Mary Berry who will be presenting ‘Understanding the Shopper’s Path to (Fresh-Prepared) Purchase’ on Day 1 of the conference (3:45pm – 4:15pm).
-
Ipsos Retail Performance Shortlisted for Retail Systems Award
We are delighted to have been shortlisted for the Retail Partnership of the Year category at the Retail Systems Awards 2017.
-
What’s Your Brand’s Social Category?
Consumers see brands as belonging to categories based on their own perception and life experience. Once consumers pigeonhole a brand, it is hard for the brand to easily change that category perception.
-
[WEBINAR] Measuring the ROI of Your VOC
On August 9, Join us for a webinar during which we will discuss the three main questions you should ask when determining if you are maximizing the ROI of your VOC program.
-
Opinion Polls: Why They Remain the Reference
The last year has seen opinion and election polling subjected to both criticism and praise. Here we review the evidence, looking particularly at recent experiences in the US, UK, France and the Netherlands.
-
Conquering Complexity: The coming revolution in oncology biomarker testing
Despite the advent of targeted therapies and the associated rise in the use of companion and complementary diagnostics, we are only just emerging from the initial exploratory stages of oncology biomarker testing. As will be argued in this paper, we are on the cusp of a much more radical revolution, and the molecular diagnostics landscape is set to change dramatically in the coming decades. It is crucial that any company entering this space prepare for this imminent upheaval and plan their launch strategy accordingly.